Brand profile · Biotechnology Research

Neurotech International Ltd

Neurotech International Ltd runs a Biotechnology Research operation from Nedlands. It is publicly held, and its site is neurotechinternational.com. It holds two addresses on record across two office countries. Headcount on record is 9. Its work is tagged product development, medical research and clinical research. One Australian registration (ABN) is a confirmed match. The record links five similar brands, most of them in Biotechnology Research.

Profile live Public Company Founded 2016 1 entity ABN 2 office countries
Registry verified · ABR

Key facts

Counted staff
9
self-reported band not used
Founded
2016
10 years
Legal entities
1
ABR
Office countries
2
2 addresses
Funding rounds
None on record
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • NEUROTECH INTERNATIONAL LIMITED

    ABN73610205402

    WAHigh confidenceMatched on exact nameABR

Legal entities

Neurotech International Ltd: 1 registry entityNeurotech International Ltd is linked to 1 registry entity: NEUROTECH INTERNATIONAL LIMITED (ABN 73610205402, candidate).Neurotech International LtdNEUROTECHINTERNATIONAL LIMITEDABN 73610205402Candidate · High confidence
Show as table · Neurotech International Ltd: 1 registry entity
Neurotech International Ltd: 1 registry entity
NEUROTECH INTERNATIONAL LIMITEDABN 73610205402
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Neurotech International Limited (ASX:NTI) is a clinical-stage biopharmaceutical development company focused predominately on paediatric neurological disorders.

Neurotech has completed a Phase I/II clinical trial in Autism Spectrum Disorder (ASD), which demonstrated safety and efficacy results at 28 days, 20 weeks and 32 weeks of daily treatment with NTI164. The Company commenced a Phase II/III randomised, double-blind, placebo-controlled clinical trial in ASD in Q4 CY2022.

The Company will also be conducting additional Phase I/II trial in Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS), collectively PANDAS/PANS, along with a Phase I/II trial in Cerebral Palsy during CY2023.

Additionally, Neurotech is commercialising Mente, the world’s first home therapy that is clinically proven to increase engagement and improve relaxation in autistic children with elevated Delta band brain activity.

For more information about Neurotech please visit http://www.neurotechinternational.com

Specialties

All 9 specialties
  • Biomedical R&D
  • Product Development
  • Autism
  • Drug Development
  • Paediatric Neurology
  • Autism Spectum Disorder
  • Medical Research
  • Clinical Research
  • Medical innovation

Related specialties

Locations

2
Countries with an office address2 addresses on record

Country footprint

Offices in 2 countriesCountry footprint: 2 countries, primary AU. Codes: AU, MT.2 countriesprimary AUAUMT
Show as table · Offices in 2 countries
Offices in 2 countries
Countries2
Primary countryAU

All codes: AU MT

Addresses

  • AU145 Stirling Highway; Suite 5 CPC; Nedlands, WA 6009Primary
  • MTMalta Life Sciences Park; Block LS3,; San Gwann, San Gwann SGN3000

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Neurotech International Ltd?

One Western Australia entity on the ABR: NEUROTECH INTERNATIONAL LIMITED (ABN 73 610 205 402), high confidence.

How many people work at Neurotech International Ltd?

9 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.

Where does Neurotech International Ltd have offices?

Two addresses on record across 2 countries. Primary: 145 Stirling Highway, Suite 5 CPC, Nedlands, WA 6009.

Has Neurotech International Ltd raised funding?

None linked to this brand.

What does Neurotech International Ltd list as its specialties?

Nine tags on the brand's own list, among them product development, medical research and clinical research.

Which companies are listed alongside Neurotech International Ltd?

6 profiles list Neurotech International Ltd as a peer — 68th percentile in Biotechnology Research. It lists ten peers of its own. Invex Therapeutics and 6PR Perth list it back.

What is Neurotech International Ltd's website?